CJC-1295 Reconstitution: 5 mg Math, Blend Ratios, and BUD Rules

Add 1 mL of bacteriostatic water to a 5 mg CJC-1295 vial for a 5 mg/mL solution, or 2 mL to a 10 mg CJC-1295/Ipamorelin blend for a typical 5 mg/mL concentration across both peptides. These are standard research conventions, not fixed rules, and every reconstitution still depends on aseptic technique, accurate measurement, and vial verification. The sections below walk through the math and the bench steps so you can adjust the ratio to your own protocol.

TL;DR:

For a 10 mg blend with 5 mg of each peptide, 2 mL yields 2.5 mg/mL per component; 0.1 mL contains 250 mcg each.

Swab both stoppers with fresh alcohol wipes, let them dry for 30 to 60 seconds, add diluent down the vial wall, and swirl gently.

Verify vial mass against its Certificate of Analysis and recalculate concentration for each preparation, because blend composition changes each peptide’s amount per milliliter.

Many labs cap beyond use dates at 24 hours unless stability data supports longer storage; USP’s immediate use category ends after 4 hours.

If the solution remains cloudy or contains visible particles, discard it; do not try to clear it by shaking or use the preparation.

Neolabpeptides

Choose Research-Grade CJC-1295

Explore research peptides with third-party testing and a Certificate of Analysis included with every product, for laboratory research use only.

Visit Neolabpeptides

Materials and bench setup before reconstitution
How to calculate mg/mL and mcg per draw
Step-by-step reconstitution procedure
Quick-reference table for common concentrations and draws
Common reconstitution mistakes and how to correct them
Storage and beyond-use dating after reconstitution
Laboratory credentials behind this protocol
When to involve pharmacy or quality assurance
Where to find CJC-1295 and Ipamorelin for research
FAQ
Sources

Materials and bench setup before reconstitution

Before opening any vial, confirm you have everything needed to keep the preparation sterile and traceable. A rushed setup is where most contamination and measurement errors start.

Bacteriostatic water (BAC water): the standard diluent for lyophilized peptides intended for research reconstitution, chosen for its preservative content over sterile water for injection.
Sterile syringes and needles: a fine-gauge needle for reconstitution and a separate insulin syringe for draws, sized to the volumes in your protocol.
Alcohol swabs: fresh, individually wrapped swabs for each stopper, never reused between vials.
Nitrile or latex gloves: worn throughout handling, changed if contaminated.
A clean, dedicated work surface: wiped down and free from drafts, open windows, or sink proximity.

Before drawing anything, verify the vial’s Certificate of Analysis (COA), lot number, and labeled mass against what you ordered, and confirm whether the vial contains a single peptide or a blend, since blends change your mg-per-component math. Wipe both the peptide vial stopper and the BAC water vial stopper with a fresh alcohol swab and let them air dry for 30 to 60 seconds before any needle insertion, consistent with core infection prevention practices for preparing sterile products. Reconstitute in a clean environment away from fans, open doors, or sinks that can introduce airborne contaminants. For a deeper walkthrough of these fundamentals, our lyophilized peptides handling guide covers what to expect when a vial goes from powder to solution.

Pro Tip: Lay out all materials on a wiped-down surface before breaking the vial seal, so you are never reaching across an open vial mid-procedure.

How to calculate mg/mL and mcg per draw

Reconstitution math comes down to one formula: concentration (mg/mL) equals the vial’s peptide mass in milligrams divided by the volume of bacteriostatic water you add. Once you have mg/mL, multiply by 1,000 to get mcg/mL, which is the unit most research dosing conventions use.

Example 1: 5 mg single-peptide vial. Adding 1 mL of BAC water gives 5 mg ÷ 1 mL = 5 mg/mL, or 5,000 mcg/mL. To draw 100 mcg, you need 100 ÷ 5,000 = 0.02 mL. To draw 250 mcg, you need 0.05 mL.

Example 2: 10 mg total blend (5 mg CJC-1295 / 5 mg Ipamorelin). Adding 2 mL of BAC water gives a combined 10 mg ÷ 2 mL = 5 mg/mL total, which splits into 2.5 mg/mL per component, or 2,500 mcg/mL each. A 0.1 mL draw delivers 250 mcg of each peptide. Our reconstitution calculator guide walks through additional blend ratios if your vial differs from this split.

Syringes marked in insulin units (where 100 units equals 1 mL) make small-volume draws easier to read than a standard mL-graduated syringe. At 5,000 mcg/mL, 0.02 mL equals 2 units; at 2,500 mcg/mL, 0.1 mL equals 10 units. Before drawing, run a quick verification check: does the vial’s labeled mass match the COA, does your calculated concentration match what you intended, and does the draw volume correspond to the dose you are targeting. A single misplaced decimal in this step is the most common source of dosing error on the bench.

Single peptide and blend concentration calculations

Step-by-step reconstitution procedure

Once your calculations are confirmed and your workspace is set, the reconstitution itself follows a short, repeatable sequence.

Wash hands and put on gloves. Hand hygiene precedes every sterile procedure, not just the final draw.
Swab both stoppers. Wipe the CJC-1295 vial stopper and the BAC water vial stopper with separate fresh alcohol swabs, then let each air dry fully.
Draw the BAC water slowly. Insert the needle into the BAC water vial and draw the calculated volume (1 mL for a 5 mg vial, 2 mL for a 10 mg vial) without introducing air bubbles.
Inject down the vial wall. Insert the needle into the peptide vial at an angle and let the bacteriostatic water run down the interior glass wall rather than striking the lyophilized powder directly, which limits foaming.
Swirl gently; never shake. Rotate the vial slowly between your fingers until the powder fully dissolves. Vigorous shaking can denature the peptide structure.
Inspect the solution. It should be clear and free of particulates before you draw a dose.
Label the vial immediately. Record the final concentration, reconstitution date and time, and preparer initials on the vial or an attached log.
Use a fresh needle for each new entry. Swapping a fresh needle after reconstitution, rather than reusing the draw needle for storage access, keeps the stopper’s rubber seal intact and reduces coring.

If your protocol calls for splitting a reconstituted vial into smaller aliquots for separate storage, treat that step with the same aseptic rigor as the original reconstitution. Aliquoting introduces additional stopper punctures and transfer points, each one a fresh opportunity for contamination, which is why institutions working under full sterile-compounding programs apply stricter environmental controls once a preparation moves beyond single-use handling. Our aseptic technique SOP walks through a compressed version of this sequence for a quick bench refresher.

Pro Tip: Keep your calculation sheet next to the vial while you draw, and read the concentration back out loud before filling the syringe. It catches arithmetic errors before they become dosing errors.

Quick-reference table for common concentrations and draws

Once a vial is reconstituted, the remaining work is translating a target mcg dose into a precise syringe reading. The table below covers the three most common CJC-1295 preparations.

Reconstitution	Concentration	100 mcg draw	250 mcg draw	250 mcg draw
5 mg + 1 mL BAC	5,000 mcg/mL	0.02 mL (2 units)	0.05 mL (5 units)	0.05 mL (5 units)
10 mg + 2 mL BAC	5,000 mcg/mL	0.02 mL (2 units)	0.05 mL (5 units)	0.05 mL (5 units)
5 mg/5 mg blend + 2 mL BAC	2,500 mcg/mL each	0.05 mL (5 units)	0.10 mL (10 units)	0.10 mL (10 units)

Choose a syringe with graduations fine enough to read your calculated draw volume without estimating between lines.
Minimize dead space by selecting a syringe and needle combination rated for low dead volume, which matters most at small volume draws.
These microgram figures serve as general research conventions rather than fixed dosing standards; always compute concentrations from your vial’s labeled mass and diluent volume before drawing.

Common reconstitution mistakes and how to correct them

A handful of errors account for most failed reconstitutions, and nearly all of them trace back to rushing the setup or skipping verification.

Injecting BAC water directly onto the powder instead of down the vial wall often causes foaming, which can trap air and make it harder to judge full dissolution.
Shaking the vial to speed up dissolving is one of the most common causes of degraded peptide structure. Swirl instead, and give it a minute longer if needed.
Reusing syringes or needles across vials or draws introduces contamination risk and can core the rubber stopper, leaving rubber particulates in solution.
Arithmetic errors in dilution math (misplacing a decimal, mixing up mg and mcg) are the most common dosing mistake and the reason a verification checklist matters every time, not just the first time.
Proceeding despite visible particulates, cloudiness, or a COA mismatch risks using a compromised preparation. When in doubt, discard the vial and start over with a new one.

If a vial has not fully dissolved after a reasonable swirling period, let it sit briefly at room temperature and try again rather than forcing it with agitation. A solution that stays cloudy or develops visible particulates should be discarded, not used.

Storage and beyond-use dating after reconstitution

Once reconstituted, CJC-1295 is generally stored refrigerated for short-term use, with aliquoting and freezing considered for longer storage windows. Repeated freeze-thaw cycles and the peptide’s tendency to adsorb to container surfaces are both factors that can reduce the usable quantity in solution over time, so many labs limit a vial to a small number of freeze-thaw cycles and aliquot early rather than refreezing a partially used vial.

FDA guidance on mixed and diluted biological products makes clear that these preparations are susceptible to microbial proliferation, and that assigning a beyond-use date beyond short timeframes requires stability testing and scientific justification rather than relying on informal convention. In practice, this means outsourcing facilities and many labs cap BUDs at 24 hours unless they have stability data supporting a longer window.

USP General Chapter 797 separately defines immediate-use compounded sterile preparations as those administered within 4 hours of preparation, a narrower category than general refrigerated storage, and sets the conditions under which full sterile-compounding facility controls must apply instead of bench-level aseptic technique.

Store reconstituted vials refrigerated between uses and avoid repeated temperature swings.
Aliquot into separate vials early if you expect to use the preparation across multiple sessions, to limit freeze-thaw cycles on any single aliquot.
Protect vials from direct light, since peptide stability can be sensitive to both temperature and light exposure.
Treat any BUD beyond an immediate-use window as something that needs its own stability justification, not an assumption carried over from community practice.

For a longer breakdown of refrigeration and freezing timelines across different peptide types, see our peptide storage conditions guide.

Laboratory credentials behind this protocol

A Certificate of Analysis accompanies every lot, documenting identity and purity so researchers can confirm what they are reconstituting before it reaches the vial.

Each product listing links its own lot-specific COA for direct verification.
Our mixing and SOP guidance covers bench technique for labs running multiple peptide preparations in parallel.
Our lyophilized peptide handling guide and aseptic technique SOP are available for teams standardizing their own internal protocols.

When to involve pharmacy or quality assurance

In my view, the point where a lab should loop in institutional pharmacy or QA is not when a protocol gets complicated. It is when someone starts asking a reconstituted vial to last longer than the evidence supports, whether that means batching multiple vials, repackaging into unlabeled containers, or stretching a BUD past 24 hours without stability data behind it. Those are QA questions, not bench conventions, and research-use guidance like this protocol stops short of answering them for you.

— Stephan

Where to find CJC-1295 and Ipamorelin for research

An Ipamorelin/CJC-1295 blend at 5 mg/5 mg (10 mg total) per vial is available, with a Certificate of Analysis published for the lot.

Neolabpeptides

Each vial includes COA documentation covering purity and identity verification.
Bacteriostatic water and syringes for reconstitution are available alongside peptide orders in a lab supplies category.
Related research compounds, including growth hormone secretagogues, are organized by category for researchers building broader protocols.

Every product we offer is intended for laboratory research only and is not approved for human or veterinary use.

FAQ

How much BAC water should I mix with CJC-1295?

For a 5 mg vial, 1 mL of bacteriostatic water yields a concentration commonly used in research; this is a convention rather than a fixed rule. Adjust the volume based on your target concentration, recalculating mg/mL as vial mass divided by diluent volume.

How do I reconstitute a 5 mg CJC-1295 vial?

Swab both the CJC-1295 vial and the bacteriostatic water vial stoppers with fresh alcohol swabs and let them air dry, consistent with core aseptic technique guidance. Draw 1 mL of bacteriostatic water, inject it slowly down the inside wall of the peptide vial, and swirl gently until fully dissolved without shaking.

How do I reconstitute a 10 mg CJC-1295/Ipamorelin blend?

Adding 2 mL of bacteriostatic water to a 10 mg total blend vial (5 mg CJC-1295, 5 mg Ipamorelin) gives a combined 5 mg/mL concentration, or 2.5 mg/mL per component. Follow the same aseptic sequence: swab both stoppers, inject the diluent down the vial wall, and swirl rather than shake until clear.

How much bacteriostatic water should I use with peptides generally?

The right volume depends on the vial’s labeled mass and your target concentration, calculated as mg divided by mL of diluent added. Many research protocols use 1 to 2 mL for typical 5 to 10 mg vials, but you should always confirm the specific vial’s mass against its Certificate of Analysis before calculating.

How long does reconstituted CJC-1295 stay stable?

Reconstituted peptides are generally used within a short refrigerated window, with FDA guidance on mixed biological products noting that any beyond-use date past short timeframes requires stability testing to justify. USP <797> separately limits immediate-use preparations to administration within 4 hours unless full sterile-compounding controls are in place.